跳转至内容
Merck
CN

840875P

Avanti

18:1 PA

Avanti Research™ - A Croda Brand

别名:

1,2-二-（9Z-十八烯酰）- 锡 -甘油-3-磷酸（钠盐）；多巴；PA (18:1 (9Z)/18:1 (9Z))

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C39H72O8PNa
化学文摘社编号:
108392-02-5
分子量:
722.95
MDL number:
MFCD00674303
UNSPSC Code:
51191904
NACRES:
NA.25

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

18:1 PA, Avanti Research™ - A Croda Brand

InChI

1S/C39H73O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(40)45-35-37(36-46-48(42,43)44)47-39(41)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h17-20,37H,3-16,21-36H2,1-2H3,(H2,42,43,44);/q;+1/p-1/b19-17-,20-18-;/t37-;/m1./s1

InChI key

JUKKLZHXFHPJSF-ZBFGHDQJSA-M

SMILES string

[H][C@@](COP([O-])(O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]

description

1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt)

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 1 g (840875P-1g)
pkg of 2 × 100 mg (840875P-200mg)
pkg of 5 × 100 mg (840875P-500mg)
pkg of 1 × 25 mg (840875P-25mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand

lipid type

cardiolipins
phospholipids

shipped in

dry ice

storage temp.

−20°C

相关类别

Application

18:1 PA (1,2-二油酰-sn-丙三醇-3-磷酸盐(钠盐)):
  • 可作为脂质体用于脂质体渗漏试验
  • 可用于创建脂质体模板，以便合成磷酸钙(CaP)纳米壳
  • 可用作脂质体/脂双层成分
  • 作为神经元神经胶质培养基添加剂，用于研究星形胶质细胞磷脂酶D1 (PLD1)对于树枝状分支的作用
  • 用于细胞色素c Trp59的化学发光试验

Biochem/physiol Actions

磷脂酸(PA)起脂质信使作用。

General description

18:1 PA (1,2-二油酰-sn-丙三醇-3-磷酸盐(钠盐))是阴离子脂质。

Packaging

5 mL 透明玻璃密封安瓿 (840875P-200 mg)
5 mL 透明玻璃密封安瓿 (840875P-25 mg)
5 mL 透明玻璃密封安瓿 (840875P-500 mg)
60 mL 琥珀色广口螺旋盖玻璃瓶 (840875P-1g)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Comparison of DOPA and DPPA liposome templates for the synthesis of calcium phosphate nanoshells
Yeo CH, et al.
Ceramics International, 38(1), 561-570 null
Shutao Guo et al.
Journal of controlled release : official journal of the Controlled Release Society, 174, 137-142 (2013-11-28)
The poor solubility of cisplatin (CDDP) often presents a major obstacle in the formulation of CDDP in nanoparticles (NPs) by traditional methods. We have developed a novel method for synthesizing CDDP NPs taking advantage of its poor solubility. By mixing
Shireesha Sankella et al.
The Journal of biological chemistry, 289(8), 4762-4777 (2014-01-16)
In this study we examined the role of phosphatidic acid (PA) in hepatic glucose production (HGP) and development of hepatic insulin resistance in mice that lack 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2). Liver lysophosphatidic acid and PA levels were increased ∼2- and
Xinhui Sun et al.
Cell cycle (Georgetown, Tex.), 14(5), 721-731 (2015-01-16)
It had been known for decades that primordial follicles in mammalian ovaries are assembled with definite numbers and represent the ovarian reserve throughout the reproductive life. Intra-oocyte PI3K/mTOR pathways have been indicated to play a central role on the activation
Kathleen Frondorf et al.
The Journal of biological chemistry, 285(21), 15837-15847 (2010-03-23)
Phosphatidic acid (PA) is a pleiotropic lipid second messenger in mammalian cells. We report here that extracellular PA acts as a leukocyte chemoattractant, as membrane-soluble dioleoyl-PA (DOPA) elicits actin polymerization and chemotaxis of human neutrophils and differentiated proleukemic HL-60 cells.
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持